Musa Khaitov
Overview
Explore the profile of Musa Khaitov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Z, Trifonova D, Tulaeva I, Riabova K, Karsonova A, Kozlov E, et al.
Front Immunol
. 2023 Nov;
14:1241518.
PMID: 37928538
Albumins from animals are highly cross-reactive allergens for patients suffering from immunoglobulin E (IgE)-mediated allergy. Approximately 20-30% of cat and dog allergic patients show IgE reactivity and mount IgE-mediated allergic...
2.
Khaitov M, Shilovskiy I, Valenta R, Weber M, Korneev A, Tulaeva I, et al.
Allergy
. 2023 Oct;
79(4):1001-1017.
PMID: 37855043
Background: IgE cross-sensitization to major birch pollen allergen Bet v 1 and pathogenesis-related (PR10) plant food allergens is responsible for the pollen-food allergy syndrome. Methods: We designed a recombinant protein,...
3.
Brazhnikov G, Smolnikov E, Litovkina A, Jiang T, Shatilov A, Tulaeva I, et al.
Allergy
. 2023 Sep;
78(12):3136-3153.
PMID: 37701941
Background: The nature of epitopes on Bet v 1 recognized by natural IgG antibodies of birch pollen allergic patients and birch pollen-exposed but non-sensitized subjects has not been studied in...
4.
Gudima G, Kofiadi I, Shilovskiy I, Kudlay D, Khaitov M
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37240213
Since the beginning of the COVID-19 pandemic, the scientific community has focused on prophylactic vaccine development. In parallel, the experience of the pharmacotherapy of this disease has increased. Due to...
5.
Byazrova M, Gattinger P, Astakhova E, Hofer G, Khaitov M, Filatov A, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982183
Millions of people have been vaccinated with Gam-COVID-Vac but fine specificities of induced antibodies have not been fully studied. Plasma from 12 naïve and 10 coronavirus disease 2019 (COVID-19) convalescent...
6.
Khaitov M, Nikonova A, Kofiadi I, Shilovskiy I, Smirnov V, Elisytina O, et al.
Allergy
. 2023 Feb;
78(6):1639-1653.
PMID: 36721963
Background: Severe acute respiratory syndrome corona virus (SARS-CoV-2) infection frequently causes severe and prolonged disease but only few specific treatments are available. We aimed to investigate safety and efficacy of...
7.
Litovkina A, Byazrova M, Smolnikov E, Nikonova A, Elisyutina O, Fedenko E, et al.
Pediatr Allergy Immunol
. 2022 Dec;
33(12):e13891.
PMID: 36564883
No abstract available.
8.
Sousa-Pinto B, Anto A, Berger M, Dramburg S, Pfaar O, Klimek L, et al.
Clin Transl Allergy
. 2022 Nov;
12(11):e12208.
PMID: 36434742
Digital health is an umbrella term which encompasses eHealth and benefits from areas such as advanced computer sciences. eHealth includes mHealth apps, which offer the potential to redesign aspects of...
9.
Sousa-Pinto B, Schunemann H, Sa-Sousa A, Vieira R, Amaral R, Anto J, et al.
Allergy
. 2022 Nov;
78(4):968-983.
PMID: 36325824
Introduction: Data from mHealth apps can provide valuable information on rhinitis control and treatment patterns. However, in MASK-air®, these data have only been analyzed cross-sectionally, without considering the changes of...
10.
Sousa-Pinto B, Schunemann H, Sa-Sousa A, Vieira R, Amaral R, Anto J, et al.
Allergy
. 2022 May;
77(10):3002-3014.
PMID: 35567393
Background: Different treatments exist for allergic rhinitis (AR), including pharmacotherapy and allergen immunotherapy (AIT), but they have not been compared using direct patient data (i.e., "real-world data"). We aimed to...